UBS (Lux) Equity Fund - Biotech Q Fonds
120,46
EUR
+0,53
EUR
+0,44
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,48% |
| Ionis Pharmaceuticals Inc | US4622221004 | 4,79% |
| Guardant Health Inc | US40131M1099 | 4,74% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,36% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 4,02% |
| Neurocrine Biosciences Inc | US64125C1099 | 3,89% |
| Amgen Inc | US0311621009 | 3,60% |
| Gilead Sciences Inc | US3755581036 | 3,46% |
| Denali Therapeutics Inc | US24823R1059 | 3,30% |
| AbbVie Inc | US00287Y1091 | 3,20% |
| Sonstige | 55,15% |